News
We are pleased to announce that funds have been awarded to a researcher with Johns Hopkins University.
MoreWe’re feeling so optimistic about the new year, given the accelerated progress we’re seeing in our search for therapies—and ultimately, a cure—for ataxia-telangiectasia (A-T)!
MoreWe’re thrilled to share encouraging initial results from a study funded by the A-T Children’s Project and conducted by Charles River Laboratories.
MoreThe Jeff Jehlik Memorial Fund Will Match Your “Giving Tuesday” Donation for A-T up to $100,000!
MoreThe A-T Clinical Center has provided recommendations for vaccinations this flu season.
MoreThe A-T Children’s Project has available funds for a grant to test gene editing technologies to restore ATM protein function in cells from children with ataxia-telangiectasia.
MoreThe A-TCP is hosting an international Gene Therapy for A-T conference in November.
MoreA-T Clinic Nurse, Jenny Wright, RN is the recipient of the 2024 Art of Nursing award!
MoreThe A-TCP is hosting IlluminATion: A BioPharma Leadership Ball on May 11 in Boston to shine a light on A-T. Join us!
MoreQuince Therapeutics is advancing a phase 3 clinical trial to evaluate EryDex, a potential new treatment for ataxia-telangiectasia (A-T).
More